Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CG Oncology, Inc.(CGON) | 1,131,501 | 1,131,501 | 0 | $27.72M | $29.42M | 19.24% | +$1.70M |
| UroGen Pharma Ltd.(URGN) | 1,516,303 | 1,259,749 | -256,554 | $16.77M | $17.26M | 11.29% | +$488.2K |
| Y-Mabs Therapeutics Inc | 3,235,387 | 3,418,995 | +183,608 | $14.33M | $15.42M | 10.09% | +$1.09M |
| Puma Biotechnology, Inc.(PBYI) | 3,940,052 | 4,131,299 | +191,247 | $11.66M | $14.17M | 9.27% | +$2.51M |
| Candel Therapeutics, Inc.(CADL) | 2,152,252 | 2,580,517 | +428,265 | $12.16M | $13.06M | 8.54% | +$897.2K |
| Trevi Therapeutics, Inc.(TRVI) | 2,144,844 | 2,144,844 | 0 | $13.49M | $11.73M | 7.67% | -$1.76M |
| Terns Pharmaceuticals Inc | 1,971,264 | 1,971,264 | 0 | $5.44M | $7.35M | 4.81% | +$1.91M |
| OnKure Therapeutics, Inc.CL A(OKUR) | 1,439,674 | 2,839,674 | +1,400,000 | $5.12M | $6.79M | 4.44% | +$1.66M |
| Cybin D/B/A Helus Pharma(HELP) | 734,394 | 734,394 | 0 | $4.66M | $6.16M | 4.03% | +$1.50M |
| Bicara Therapeutics | 643,382 | 643,382 | 0 | $8.38M | $5.98M | 3.91% | -$2.41M |
| Protara Therapeutics, Inc.(TARA) | 1,279,800 | 1,752,115 | +472,315 | $5.45M | $5.31M | 3.47% | -$143.0K |
| Cardiff Oncology, Inc.(CRDF) | 1,442,308 | 1,408,767 | -33,541 | $4.53M | $4.44M | 2.90% | -$91.2K |
| Aura Biosciences, Inc.(AURA) | 590,508 | 595,744 | +5,236 | $1.45M | $3.73M | 2.44% | +$2.28M |
| Verastem, Inc.(VSTM) | 779,498 | 779,498 | 0 | $4.70M | $3.23M | 2.12% | -$1.47M |
| Whitehawk Therapeutics, Inc.(WHWK) | 1,139,363 | 1,139,363 | 0 | $2.03M | $2.13M | 1.39% | +$102.5K |
| BioAtla, Inc.(BCAB) | 4,032,046 | 4,835,111 | +803,065 | $1.41M | $1.91M | 1.25% | +$503.5K |
| Mural Oncology Plc | 1,269,715 | 653,779 | -615,936 | $1.60M | $1.61M | 1.06% | +$15.0K |
| Yarrow Bioscience Inc(YARW) | 785,938 | 736,572 | -49,366 | $1.24M | $1.22M | 0.79% | -$26.4K |
| Q32 Bio Inc.(QTTB) | 803,425 | 803,425 | 0 | $1.33M | $1.20M | 0.78% | -$128.5K |
| Acrivon Therapeutics Inc | 405,237 | 405,237 | 0 | $822.6K | $482.2K | 0.32% | -$340.4K |
| X4 Pharmaceuticals, Inc.(XFOR) | 7,310,650 | 153,730 | -7,156,920 | $1.75M | $292.1K | 0.19% | -$1.46M |
| Optinose Inc | 422,814 | 0 | -422,814 | $3.88M | $0 | — | -$3.88M |